Dova Receives FDA Nod For Bleeding Disorder Treatment; Rival Drug Awaits Clearance

By: via Benzinga
Shares of Dova Pharmaceuticals Inc (NASDAQ: DOVA) last traded down over 7 percent Monday after which trading was halted in ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.